• Education
    • Higher Education
    • Scholarships & Grants
    • Online Learning
    • School Reforms
    • Research & Innovation
  • Lifestyle
    • Travel
    • Food & Drink
    • Fashion & Beauty
    • Home & Living
    • Relationships & Family
  • Technology & Startups
    • Software & Apps
    • Startup Success Stories
    • Startups & Innovations
    • Tech Regulations
    • Venture Capital
    • Artificial Intelligence
    • Cybersecurity
    • Emerging Technologies
    • Gadgets & Devices
    • Industry Analysis
  • About us
  • Contact
  • Advertise with Us
  • Privacy & Policy
Today Headline
  • Home
  • World News
    • Us & Canada
    • Europe
    • Asia
    • Africa
    • Middle East
  • Politics
    • Elections
    • Political Parties
    • Government Policies
    • International Relations
    • Legislative News
  • Business & Finance
    • Market Trends
    • Stock Market
    • Entrepreneurship
    • Corporate News
    • Economic Policies
  • Science & Environment
    • Space Exploration
    • Climate Change
    • Wildlife & Conservation
    • Environmental Policies
    • Medical Research
  • Health
    • Public Health
    • Mental Health
    • Medical Breakthroughs
    • Fitness & Nutrition
    • Pandemic Updates
  • Sports
    • Football
    • Basketball
    • Tennis
    • Olympics
    • Motorsport
  • Entertainment
    • Movies
    • Music
    • TV & Streaming
    • Celebrity News
    • Awards & Festivals
  • Crime & Justice
    • Court Cases
    • Cybercrime
    • Policing
    • Criminal Investigations
    • Legal Reforms
No Result
View All Result
  • Home
  • World News
    • Us & Canada
    • Europe
    • Asia
    • Africa
    • Middle East
  • Politics
    • Elections
    • Political Parties
    • Government Policies
    • International Relations
    • Legislative News
  • Business & Finance
    • Market Trends
    • Stock Market
    • Entrepreneurship
    • Corporate News
    • Economic Policies
  • Science & Environment
    • Space Exploration
    • Climate Change
    • Wildlife & Conservation
    • Environmental Policies
    • Medical Research
  • Health
    • Public Health
    • Mental Health
    • Medical Breakthroughs
    • Fitness & Nutrition
    • Pandemic Updates
  • Sports
    • Football
    • Basketball
    • Tennis
    • Olympics
    • Motorsport
  • Entertainment
    • Movies
    • Music
    • TV & Streaming
    • Celebrity News
    • Awards & Festivals
  • Crime & Justice
    • Court Cases
    • Cybercrime
    • Policing
    • Criminal Investigations
    • Legal Reforms
No Result
View All Result
Today Headline
No Result
View All Result
Home Science & Environment Medical Research

Dexcom receives FDA clearance for G7 15 Day glucose monitoring system

April 14, 2025
in Medical Research
Reading Time: 5 mins read
A A
0
Dexcom receives FDA clearance for G7 15 Day glucose monitoring system
8
SHARES
18
VIEWS
Share on FacebookShare on Twitter



Glucose monitoring specialist Dexcom announced it received FDA clearance for its G7 15 Day continuous glucose monitoring (CGM) system for people 18 and older with type 1, type 2 and gestational diabetes. 

G7 15 Day, scheduled to launch in the second half of this year, will have a 15.5-day wear time (including a 12-hour grace period) and last 15% longer than Dexcom G7, according to the company. 

The new system sends real-time glucose information to the Dexcom G7 app or receiver every five minutes via a sensor without the need for fingersticks or scanning.

The system has an overall mean absolute relative difference (MARD) of 8.0%. According to the NIH National Library of Medicine, MARD is a parameter used to characterize the measurement performance of CGM systems. 

Dexcom G7 is waterproof and hands-free and has the ability to connect the sensor directly to an Apple Watch.

It also has an automated activity logging feature that allows end users to input meal and medication information.

The Dexcom Clarity mobile app is compatible with a smartphone or computer and provides glucose patterns and statistics as well as the means to share glucose data with caregivers and family members. 

Meanwhile, the company is working with insulin pump partners to ensure Dexcom G7 15 Day will be compatible with automated insulin delivery systems. 

“The approval of Dexcom G7 15 Day marks another major innovation for Dexcom,” Jake Leach, executive vice president and chief operating officer at Dexcom, said in a statement. 

“By listening to the needs of our users, we’re proud to offer the longest-lasting wearable and most accurate CGM, giving people the knowledge to better control their diabetes with our best-in-class technology. This milestone sets a new standard in CGM and is a testament to our continued leadership in glucose biosensing.”

THE LARGER TREND

In March, cardiometabolic digital diagnostics company Nanowear announced a licensing and data partnership with Dexcom to integrate glucose data from the Dexcom G7 into its SimpleSense nanotechnology-enabled wearable. 

Nanowear provides home-based, AI-enabled digital diagnostics for cardiometabolic health. The company’s FDA-cleared SimpleSense wearable reads patient vitals, including respiration rate, heart rate, blood pressure, physical activity and lung volume. 

In 2024, Dexcom made a $75 million strategic investment in health-tracking ring maker Oura and established a strategic partnership to enable two-way data flow between Dexcom’s CGM and the Oura Ring.

Dexcom contributed $75 million to Oura’s Series D funding round, which brought Oura’s valuation to more than $5 billion.

Via the partnership, users of both company’s products gained access to glucose data from Dexcom glucose biosensors and sleep, heart health, stress, vital-sign and activity data from the Oura Ring available on Dexcom’s app and Oura’s app. 

That same year Dexcom expanded its diabetes-management capabilities and offered direct connectivity to the Apple Watch for its G7 CGM system via a dedicated Bluetooth connection. 

The feature gives users the ability to check their glucose readings in real-time without having their iPhone in hand. 

In 2022, Dexcom G7 CGM was cleared by the FDA. That model was for individuals with all types of diabetes, ages two and older.

Other companies in the CGM space include Abbott, which in 2024 announced its CGM system Lingo could be purchased in the U.S. without a prescription.

Lingo contains a biosensor and mobile app based on Abbott’s FreeStyle Libre continuous glucose monitoring technology. The system is a biowearable product intended for people 18 and older who are not taking insulin. 

The system tracks glucose in real time and provides end users with personal insights and coaching with the aim of helping build healthy habits, retrain metabolism and improve overall health. 

That same year, Medtronic received FDA clearance for the Simplera CGM, the company’s first disposable, all-in-one CGM, which is half the size of previous Medtronic CGMs. 

The Simplera platform featured the company’s CGM form factor and included the Simplera CGM designed to be used as part of a Smart MDI system with the InPen smart insulin pen and the Simplera Sync sensor, which was designed to be integrated with the MiniMed 780G insulin system.

Last year, Medtronic issued a voluntary recall of its MiniMed 600 series or 700 series insulin pumps due to the pump’s potentially shortened battery life. 

The company notified customers that they should monitor their MiniMed pump’s built-in alarms and alerts to keep track of battery status and contact the company if they notice changes in the pump’s battery life. 



Glucose monitoring specialist Dexcom announced it received FDA clearance for its G7 15 Day continuous glucose monitoring (CGM) system for people 18 and older with type 1, type 2 and gestational diabetes. 

G7 15 Day, scheduled to launch in the second half of this year, will have a 15.5-day wear time (including a 12-hour grace period) and last 15% longer than Dexcom G7, according to the company. 

The new system sends real-time glucose information to the Dexcom G7 app or receiver every five minutes via a sensor without the need for fingersticks or scanning.

The system has an overall mean absolute relative difference (MARD) of 8.0%. According to the NIH National Library of Medicine, MARD is a parameter used to characterize the measurement performance of CGM systems. 

Dexcom G7 is waterproof and hands-free and has the ability to connect the sensor directly to an Apple Watch.

It also has an automated activity logging feature that allows end users to input meal and medication information.

The Dexcom Clarity mobile app is compatible with a smartphone or computer and provides glucose patterns and statistics as well as the means to share glucose data with caregivers and family members. 

Meanwhile, the company is working with insulin pump partners to ensure Dexcom G7 15 Day will be compatible with automated insulin delivery systems. 

“The approval of Dexcom G7 15 Day marks another major innovation for Dexcom,” Jake Leach, executive vice president and chief operating officer at Dexcom, said in a statement. 

“By listening to the needs of our users, we’re proud to offer the longest-lasting wearable and most accurate CGM, giving people the knowledge to better control their diabetes with our best-in-class technology. This milestone sets a new standard in CGM and is a testament to our continued leadership in glucose biosensing.”

THE LARGER TREND

In March, cardiometabolic digital diagnostics company Nanowear announced a licensing and data partnership with Dexcom to integrate glucose data from the Dexcom G7 into its SimpleSense nanotechnology-enabled wearable. 

Nanowear provides home-based, AI-enabled digital diagnostics for cardiometabolic health. The company’s FDA-cleared SimpleSense wearable reads patient vitals, including respiration rate, heart rate, blood pressure, physical activity and lung volume. 

In 2024, Dexcom made a $75 million strategic investment in health-tracking ring maker Oura and established a strategic partnership to enable two-way data flow between Dexcom’s CGM and the Oura Ring.

Dexcom contributed $75 million to Oura’s Series D funding round, which brought Oura’s valuation to more than $5 billion.

Via the partnership, users of both company’s products gained access to glucose data from Dexcom glucose biosensors and sleep, heart health, stress, vital-sign and activity data from the Oura Ring available on Dexcom’s app and Oura’s app. 

That same year Dexcom expanded its diabetes-management capabilities and offered direct connectivity to the Apple Watch for its G7 CGM system via a dedicated Bluetooth connection. 

The feature gives users the ability to check their glucose readings in real-time without having their iPhone in hand. 

In 2022, Dexcom G7 CGM was cleared by the FDA. That model was for individuals with all types of diabetes, ages two and older.

Other companies in the CGM space include Abbott, which in 2024 announced its CGM system Lingo could be purchased in the U.S. without a prescription.

Lingo contains a biosensor and mobile app based on Abbott’s FreeStyle Libre continuous glucose monitoring technology. The system is a biowearable product intended for people 18 and older who are not taking insulin. 

The system tracks glucose in real time and provides end users with personal insights and coaching with the aim of helping build healthy habits, retrain metabolism and improve overall health. 

That same year, Medtronic received FDA clearance for the Simplera CGM, the company’s first disposable, all-in-one CGM, which is half the size of previous Medtronic CGMs. 

The Simplera platform featured the company’s CGM form factor and included the Simplera CGM designed to be used as part of a Smart MDI system with the InPen smart insulin pen and the Simplera Sync sensor, which was designed to be integrated with the MiniMed 780G insulin system.

Last year, Medtronic issued a voluntary recall of its MiniMed 600 series or 700 series insulin pumps due to the pump’s potentially shortened battery life. 

The company notified customers that they should monitor their MiniMed pump’s built-in alarms and alerts to keep track of battery status and contact the company if they notice changes in the pump’s battery life. 

Previous Post

FDA warns about fake Ozempic in U.S. supply chain

Next Post

NOAA scientists are cleaning bathrooms in Seattle

Related Posts

Trump Pushes Debunked Theory of ‘Transgender Mice’ as He Thanks Musk for His ‘Service’

May 30, 2025
5
skin cancer

Who should be screened for skin cancer?

May 30, 2025
7
Next Post
Trump Officials Release Water That Experts Say Will Serve Little Use

NOAA scientists are cleaning bathrooms in Seattle

  • Trending
  • Comments
  • Latest
Family calls for change after B.C. nurse dies by suicide after attacks on the job

Family calls for change after B.C. nurse dies by suicide after attacks on the job

April 2, 2025
Pioneering 3D printing project shares successes

Product reduces TPH levels to non-hazardous status

November 27, 2024

Hospital Mergers Fail to Deliver Better Care or Lower Costs, Study Finds todayheadline

December 31, 2024

Police ID man who died after Corso Italia fight

December 23, 2024
Harris tells supporters 'never give up' and urges peaceful transfer of power

Harris tells supporters ‘never give up’ and urges peaceful transfer of power

0
Des Moines Man Accused Of Shooting Ex-Girlfriend's Mother

Des Moines Man Accused Of Shooting Ex-Girlfriend’s Mother

0

Trump ‘looks forward’ to White House meeting with Biden

0
Catholic voters were critical to Donald Trump’s blowout victory: ‘Harris snubbed us’

Catholic voters were critical to Donald Trump’s blowout victory: ‘Harris snubbed us’

0
Musk vows to stay Trump's 'friend,' denies drug allegations in odd black-eyed farewell

Musk vows to stay Trump’s ‘friend,’ denies drug allegations in odd black-eyed farewell

May 31, 2025

Moderna Receives U.S. FDA Approval for COVID-19 Vaccine mNEXSPIKE todayheadline

May 31, 2025

Sri Lanka foreign exchange earnings exceed imports by $531mn in April 2025 todayheadline

May 31, 2025
Venus as a morning star

Venus at greatest western elongation

May 31, 2025

Recent News

China’s navy conducts combat patrols near disputed South China Sea shoal

China’s navy conducts combat patrols near disputed South China Sea shoal

May 31, 2025
0
Musk vows to stay Trump's 'friend,' denies drug allegations in odd black-eyed farewell

Musk vows to stay Trump’s ‘friend,’ denies drug allegations in odd black-eyed farewell

May 31, 2025
2

Moderna Receives U.S. FDA Approval for COVID-19 Vaccine mNEXSPIKE todayheadline

May 31, 2025
4

Sri Lanka foreign exchange earnings exceed imports by $531mn in April 2025 todayheadline

May 31, 2025
3

TodayHeadline is a dynamic news website dedicated to delivering up-to-date and comprehensive news coverage from around the globe.

Follow Us

Browse by Category

  • Africa
  • Asia
  • Basketball
  • Business & Finance
  • Climate Change
  • Crime & Justice
  • Cybersecurity
  • Economic Policies
  • Elections
  • Entertainment
  • Entrepreneurship
  • Environmental Policies
  • Europe
  • Football
  • Gadgets & Devices
  • Health
  • Medical Research
  • Mental Health
  • Middle East
  • Motorsport
  • Olympics
  • Politics
  • Public Health
  • Relationships & Family
  • Science & Environment
  • Software & Apps
  • Space Exploration
  • Sports
  • Stock Market
  • Technology & Startups
  • Tennis
  • Travel
  • Uncategorized
  • Us & Canada
  • Wildlife & Conservation
  • World News

Recent News

China’s navy conducts combat patrols near disputed South China Sea shoal

China’s navy conducts combat patrols near disputed South China Sea shoal

May 31, 2025
Musk vows to stay Trump's 'friend,' denies drug allegations in odd black-eyed farewell

Musk vows to stay Trump’s ‘friend,’ denies drug allegations in odd black-eyed farewell

May 31, 2025
  • Education
  • Lifestyle
  • Technology & Startups
  • About us
  • Contact
  • Advertise with Us
  • Privacy & Policy

© 2024 Todayheadline.co

Welcome Back!

OR

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Business & Finance
  • Corporate News
  • Economic Policies
  • Entrepreneurship
  • Market Trends
  • Crime & Justice
  • Court Cases
  • Criminal Investigations
  • Cybercrime
  • Legal Reforms
  • Policing
  • Education
  • Higher Education
  • Online Learning
  • Entertainment
  • Awards & Festivals
  • Celebrity News
  • Movies
  • Music
  • Health
  • Fitness & Nutrition
  • Medical Breakthroughs
  • Mental Health
  • Pandemic Updates
  • Lifestyle
  • Fashion & Beauty
  • Food & Drink
  • Home & Living
  • Politics
  • Elections
  • Government Policies
  • International Relations
  • Legislative News
  • Political Parties
  • Africa
  • Asia
  • Europe
  • Middle East
  • Artificial Intelligence
  • Cybersecurity
  • Emerging Technologies
  • Gadgets & Devices
  • Industry Analysis
  • Basketball
  • Football
  • Motorsport
  • Olympics
  • Climate Change
  • Environmental Policies
  • Medical Research
  • Science & Environment
  • Space Exploration
  • Wildlife & Conservation
  • Sports
  • Tennis
  • Technology & Startups
  • Software & Apps
  • Startup Success Stories
  • Startups & Innovations
  • Tech Regulations
  • Venture Capital
  • Uncategorized
  • World News
  • Us & Canada
  • Public Health
  • Relationships & Family
  • Travel
  • Research & Innovation
  • Scholarships & Grants
  • School Reforms
  • Stock Market
  • TV & Streaming
  • Advertise with Us
  • Privacy & Policy
  • About us
  • Contact

© 2024 Todayheadline.co